Elbasvir
id:
elbasvir-274-8139400
title:
Elbasvir
text:
Elbasvir is a drug approved by the FDA in January 2016 for the treatment of hepatitis C. It was developed by Merck and completed Phase III trials, used in combination with the NS3/4A protease inhibitor grazoprevir under the trade name Zepatier, either with or without ribavirin. Elbasvir is a highly potent and selective NS5A inhibitor of the hepatitis C virus NS5A replication complex. It has only been investigated as a combination product with other complementary hepatitis C antiviral drugs such
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Elbasvir
date created:
date modified:
2023-11-17T07:51:25Z
main entity:
{"identifier":"Q19904043","url":"https://www.wikidata.org/entity/Q19904043"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/35/Elbasvir.svg","width":512,"height":194}
fields total:
13
integrity:
15